This work is licensed under the Creative Commons Attribution 4.0 International License.
Singh D, Gupta S, Verma I, Morsy MA, Nair AB, Ahmed AF. Hidden pharmacological activities of valproic acid: A new insight. Biomed Pharmacother 2021;142:112021. doi: 10.1016/j.biopha.2021.112021SinghDGuptaSVermaIMorsyMANairABAhmedAFHidden pharmacological activities of valproic acid: A new insightBiomed Pharmacother202114211202110.1016/j.biopha.2021.11202134463268Open DOISearch in Google Scholar
Pitt B, Sutton NR, Wang Z, Goonewardena SN, Holinstat M. Potential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19. Eur J Pharmacol 2021;898:173988. doi: 10.1016/j.ejphar.2021.173988PittBSuttonNRWangZGoonewardenaSNHolinstatMPotential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19Eur J Pharmacol202189817398810.1016/j.ejphar.2021.173988792386833667455Open DOISearch in Google Scholar
Đikić D, Jutrić D, Dominko K. The dual nature of the antiepileptic drug valproic acid, with possible beneficial effects in Alzheimer’s disease. SEEMEDJ 2017;1:74–89. doi: 10.26332/seemedj.v1i1.26ĐikićDJutrićDDominkoKThe dual nature of the antiepileptic drug valproic acid, with possible beneficial effects in Alzheimer’s diseaseSEEMEDJ20171748910.26332/seemedj.v1i1.26Open DOISearch in Google Scholar
NCBI. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet] [displayed 31 July 2020]. Available at https://www.ncbi.nlm.nih.gov/books/NBK548284/LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet] [displayed 31 July2020Available athttps://www.ncbi.nlm.nih.gov/books/NBK548284/Search in Google Scholar
Chaudhary S, Ganjoo P, Raiusddin S, Parvez S. Nephroprotective activities of quercetin with potential relevance to oxidative stress induced by valproic acid. Protoplasma 2015;252:209–17. doi: 10.1007/s00709-014-0670-8ChaudharySGanjooPRaiusddinSParvezSNephroprotective activities of quercetin with potential relevance to oxidative stress induced by valproic acidProtoplasma20152522091710.1007/s00709-014-0670-825000991Open DOISearch in Google Scholar
Celik E, Tunali S, Gezginci-Oktayoglu S, Bolkent S, Can A, Yanardag R. Vitamin U prevents valproic acid-induced liver injury through supporting enzymatic antioxidant system and increasing hepatocyte proliferation triggered by inflammation and apoptosis. Toxicol Mech Methods 2021;31:600–8. doi: 10.1080/15376516.2021.1943089CelikETunaliSGezginci-OktayogluSBolkentSCanAYanardagRVitamin U prevents valproic acid-induced liver injury through supporting enzymatic antioxidant system and increasing hepatocyte proliferation triggered by inflammation and apoptosisToxicol Mech Methods202131600810.1080/15376516.2021.194308934420476Open DOISearch in Google Scholar
Salimi A, Alyan N, Akbari N, Jamali Z, Pourahmad J. Selenium and L-carnitine protects from valproic acid-Induced oxidative stress and mitochondrial damages in rat cortical neurons. Drug Chem Toxicol 2020;1–8. [Online ahead of print] doi: 10.1080/01480545.2020.1810259SalimiAAlyanNAkbariNJamaliZPourahmadJSelenium and L-carnitine protects from valproic acid-Induced oxidative stress and mitochondrial damages in rat cortical neuronsDrug Chem Toxicol202018[Online ahead of print]10.1080/01480545.2020.181025932885679Open DOISearch in Google Scholar
Shirani K, Yousefsani BS, Shirani M, Karimi G. Protective effects of naringin against drugs and chemical toxins induced hepatotoxicity: A review. Phytother Res 2020;34:1734–44. doi: 10.1002/ptr.6641ShiraniKYousefsaniBSShiraniMKarimiGProtective effects of naringin against drugs and chemical toxins induced hepatotoxicity: A reviewPhytother Res20203417344410.1002/ptr.664132067280Open DOISearch in Google Scholar
Koroglu OF, Gunata M, Vardi N, Yildiz A, Ates B, Colak C, Tanriverdi LH, Parlakpinar H. Protective effects of naringin on valproic acid-induced hepatotoxicity in rats. Tissue Cell 2021;72:101526. doi: 10.1016/j.tice.2021.101526KorogluOFGunataMVardiNYildizAAtesBColakCTanriverdiLHParlakpinarHProtective effects of naringin on valproic acid-induced hepatotoxicity in ratsTissue Cell20217210152610.1016/j.tice.2021.10152633756270Open DOISearch in Google Scholar
Zhang X, Zhang Y, Gao W, Guo Z, Wang K, Liu S, Duan Z, Chen Y. Naringin improves lipid metabolism in a tissue-engineered liver model of NAFLD and the underlying mechanisms. Life Sci 2021;277:119487. doi: 10.1016/j.lfs.2021.119487ZhangXZhangYGaoWGuoZWangKLiuSDuanZChenYNaringin improves lipid metabolism in a tissue-engineered liver model of NAFLD and the underlying mechanismsLife Sci202127711948710.1016/j.lfs.2021.11948733862107Open DOISearch in Google Scholar
Syed AA, Reza MI, Shafiq M, Kumariya S, Singh P, Husain A, Hanif K, Gayen JR. Naringin ameliorates type 2 diabetes mellitus-induced steatohepatitis by inhibiting RAGE/NF-κB mediated mitochondrial apoptosis. Life Sci 2020;257:118118. doi: 10.1016/j.lfs.2020.118118SyedAARezaMIShafiqMKumariyaSSinghPHusainAHanifKGayenJRNaringin ameliorates type 2 diabetes mellitus-induced steatohepatitis by inhibiting RAGE/NF-κB mediated mitochondrial apoptosisLife Sci202025711811810.1016/j.lfs.2020.11811832702445Open DOISearch in Google Scholar
Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals. 8th ed. Washington (DC): National Academies Press; 2011.Committee for the Update of the Guide for the Care and Use of Laboratory AnimalsGuide for the Care and Use of Laboratory Animals. 8th edWashington (DC)National Academies Press;2011Search in Google Scholar
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502. doi: 10.1093/clinchem/18.6.499FriedewaldWTLevyRIFredricksonDSEstimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugeClin Chem19721849950210.1093/clinchem/18.6.499Open DOISearch in Google Scholar
Oršolić N, Landeka Jurčević I, Đikić D, Rogić D, Odeh D, Balta V, Perak Junaković E, Terzić S, Jutrić D. Effect of propolis on diet-induced hyperlipidemia and atherogenic indices in mice. Antioxidants (Basel) 201;8:156. doi: 10.3390/antiox8060156OršolićNLandekaJurčević IĐikićDRogićDOdehDBaltaVPerakJunaković ETerzićSJutrićDEffect of propolis on diet-induced hyperlipidemia and atherogenic indices in miceAntioxidants (Basel) 201815610.3390/antiox8060156Open DOISearch in Google Scholar
Đikić D, Landeka I, Knežević F, Mojsović-Ćuić A, Benković V, Horvat-Knežević A, Lončar G, Teparić R, Rogić D. Carbendazim impends hepatic necrosis when combined with imazalil or cypermethrin. Basic C l in Ph a rm a co l To x i co l 2 0 1 2 ; 1 1 0 : 4 3 3 – 4 0 . do i : 10.1111/j.1742-7843.2011.00831.xĐikićDLandekaIKneževićFMojsović-ĆuićABenkovićVHorvat-KneževićALončarGTeparićRRogićDCarbendazim impends hepatic necrosis when combined with imazalil or cypermethrinBasic Cl in Pharmacol Toxico l 2 0 1 2 ; 1 1 0 : 4 3 3 – 4 010.1111/j.1742-7843.2011.00831.x10.1111/j.1742-7843.2011.00831.xSearch in Google Scholar
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265–75. doi: 10.1016/S0021-9258(19)52451-6LowryOHRosebroughNJFarrALRandallRJProtein measurement with the Folin phenol reagentJ Biol Chem19511932657510.1016/S0021-9258(19)52451-6Open DOISearch in Google Scholar
Landeka Jurčević I, Dora M, Guberović I, Petras M, Rimac S, Brnčić, Đikić D. Polyphenols from wine lees as a novel functional bioactive compound in the protection against oxidative stress and hyperlipidaemia. Food Technol Biotechnol 2017;55:109–16. doi: 10.17113/ftb.55.01.17.4894LandekaJurčević IDoraMGuberovićIPetrasMRimacSBrnčićĐikić DPolyphenols from wine lees as a novel functional bioactive compound in the protection against oxidative stress and hyperlipidaemiaFood Technol Biotechnol2017551091610.17113/ftb.55.01.17.4894543437328559739Open DOISearch in Google Scholar
Nagababu E, Rifkind JM, Boindala S, Nakka L. Assessment of antioxidant activity of eugenol in vitro and in vivo. Methods Mol Biol 2010;610:165–80. doi: 10.1007/978-1-60327-029-8_10NagababuERifkindJMBoindalaSNakkaLAssessment of antioxidant activity of eugenol in vitro and in vivoMethods Mol Biol20106101658010.1007/978-1-60327-029-8_10320233520013178Open DOISearch in Google Scholar
Mu H, Zhou Q, Yang R, Zeng J, Li X, Zhang R, Tang W, Li H, Wang S, Shen T, Huang X, Dou L, Dong J. Naringin attenuates high fat diet induced non-alcoholic fatty liver disease and gut bacterial dysbiosis in mice. Front Microbiol 2020;11:585066. doi: 10.3389/fmicb.2020.585066MuHZhouQYangRZengJLiXZhangRTangWLiHWangSShenTHuangXDouLDongJNaringin attenuates high fat diet induced non-alcoholic fatty liver disease and gut bacterial dysbiosis in miceFront Microbiol20201158506610.3389/fmicb.2020.585066769132433281780Open DOISearch in Google Scholar
Bellringer ME, Rahman K, Coleman R. Sodium valproate inhibits the movement of secretory vesicles in rat hepatocytes. Biochem J 1988;249:513–9. doi: 10.1042/bj2490513BellringerMERahmanKColemanRSodium valproate inhibits the movement of secretory vesicles in rat hepatocytesBiochem J1988249513910.1042/bj249051311487323124828Open DOISearch in Google Scholar
Grünig D, Szabo L, Marbet M, Krähenbühl S. Valproic acid affects fatty acid and triglyceride metabolism in HepaRG cells exposed to fatty acids by different mechanisms. Biochem Pharmacol 2020;177:113860. doi: 10.1016/j.bcp.2020.113860GrünigDSzaboLMarbetMKrähenbühlSValproic acid affects fatty acid and triglyceride metabolism in HepaRG cells exposed to fatty acids by different mechanismsBiochem Pharmacol202017711386010.1016/j.bcp.2020.11386032165129Open DOISearch in Google Scholar
Lee MH, Hong I, Kim M, Lee BH, Kim JH, Kang KS, Kim HL, Yoon BI, Chung H, Kong G, Lee MO. Gene expression profiles of murine fatty liver induced by the administration of valproic acid. Toxicol Appl Pharmacol 2007;220:45–59. doi: 10.1016/j.taap.2006.12.016LeeMHHongIKimMLeeBHKimJHKangKSKimHLYoonBIChungHKongGLeeMOGene expression profiles of murine fatty liver induced by the administration of valproic acidToxicol Appl Pharmacol2007220455910.1016/j.taap.2006.12.01617292431Open DOISearch in Google Scholar
Ma L, Wang Y, Chen X, Zhao L, Guo Y. Involvement of CYP2E1-ROS-CD36/DGAT2 axis in the pathogenesis of VPA-induced hepatic steatosis in vivo and in vitro. Toxicology 2020;445:152585. doi: 10.1016/j.tox.2020.152585MaLWangYChenXZhaoLGuoYInvolvement of CYP2E1-ROS-CD36/DGAT2 axis in the pathogenesis of VPA-induced hepatic steatosis in vivo and in vitroToxicology202044515258510.1016/j.tox.2020.15258533007364Open DOISearch in Google Scholar
Bai X, Hong W, Cai P, Chen Y, Xu C, Cao D, Yu W, Zhao Z, Huang M, Jin J. Valproate induced hepatic steatosis by enhanced fatty acid uptake and triglyceride synthesis. Toxicol Appl Pharmacol 2017;324:12–25. doi: 10.1016/j.taap.2017.03.022BaiXHongWCaiPChenYXuCCaoDYuWZhaoZHuangMJinJValproate induced hepatic steatosis by enhanced fatty acid uptake and triglyceride synthesisToxicol Appl Pharmacol2017324122510.1016/j.taap.2017.03.02228366540Open DOISearch in Google Scholar
Aires CCP, Ijlst L, Stet F, Prip-Buus C, de Almeida IT, Duran M, Wanders RJ, Silva MF. Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis. Biochem Pharmacol 2010;79:792–9. doi: 10.1016/j.bcp.2009.10.011AiresCCPIjlstLStetFPrip-BuusCdeAlmeida ITDuranMWandersRJSilvaMFInhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosisBiochem Pharmacol201079792910.1016/j.bcp.2009.10.01119854160Open DOISearch in Google Scholar
Kim HJ, Oh GT, Park YB, Lee MK, Seo HJ, Choi MS. Naringin alters the cholesterol biosynthesis and antioxidant enzyme activities in LDL receptor-knockout mice under cholesterol fed condition. Life Sci 2004;74:1621–34. doi: 10.1016/j.lfs.2003.08.026KimHJOhGTParkYBLeeMKSeoHJChoiMSNaringin alters the cholesterol biosynthesis and antioxidant enzyme activities in LDL receptor-knockout mice under cholesterol fed conditionLife Sci20047416213410.1016/j.lfs.2003.08.02614738906Open DOISearch in Google Scholar
Liang H, Ward WF. PGC-1alpha: a key regulator of energy metabolism. Adv Physiol Educ 2006;30:145–51. doi: 10.1152/advan.00052.2006LiangHWardWFPGC-1alpha: a key regulator of energy metabolismAdv Physiol Educ2006301455110.1152/advan.00052.200617108241Open DOISearch in Google Scholar
van Raalte DH, Li M, Pritchard PH, Wasan KM. Peroxisome proliferator-activated receptor (PPAR)-alpha: a pharmacological target with a promising future. Pharm Res 2004;21:1531–8. doi: 10.1023/b:pham.0000041444.06122.8dvanRaalte DHLiMPritchardPHWasanKMPeroxisome proliferator-activated receptor (PPAR)-alpha: a pharmacological target with a promising futurePharm Res2004211531810.1023/b:pham.0000041444.06122.8dOpen DOISearch in Google Scholar
Tahri-Joutey M, Andreoletti P, Surapureddi S, Nasser B, Cherkaoui-Malki M, Latruffe N. Mechanisms mediating the regulation of peroxisomal fatty acid beta-oxidation by PPARα. Int J Mol Sci 2021;22:8969. doi: 10.3390/ijms22168969Tahri-JouteyMAndreolettiPSurapureddiSNasserBCherkaoui-MalkiMLatruffeNMechanisms mediating the regulation of peroxisomal fatty acid beta-oxidation by PPARαInt J Mol Sci202122896910.3390/ijms22168969839656134445672Open DOISearch in Google Scholar
Lira VA, Benton CR, Yan Z, Bonen A. PGC-1alpha regulation by exercise training and its influences on muscle function and insulin sensitivity. Am J Physiol Endocrinol Metab 2010;299:E145–61. doi: 10.1152/ajpendo.00755.2009LiraVABentonCRYanZBonenAPGC-1alpha regulation by exercise training and its influences on muscle function and insulin sensitivityAm J Physiol Endocrinol Metab2010299E1456110.1152/ajpendo.00755.2009292851320371735Open DOISearch in Google Scholar
Vluggens A, Andreoletti P, Viswakarma N, Jia Y, Matsumoto K, Kulik W, Khan M, Huang J, Guo D, Yu S, Sarkar J, Singh I, Rao MS, Wanders RJ, Reddy JK, Cherkaoui-Malki M. Reversal of mouse Acyl-CoA oxidase 1 (ACOX1) null phenotype by human ACOX1b isoform. Lab Invest 2010;90:696–708. doi: 10.1038/labinvest.2010.46VluggensAAndreolettiPViswakarmaNJiaYMatsumotoKKulikWKhanMHuangJGuoDYuSSarkarJSinghIRaoMSWandersRJReddyJKCherkaoui-MalkiMReversal of mouse Acyl-CoA oxidase 1 (ACOX1) null phenotype by human ACOX1b isoformLab Invest20109069670810.1038/labinvest.2010.4620195242Open DOISearch in Google Scholar
Reddy JK, Hashimoto T. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Annu Rev Nutr 2001;21:193–230. doi: 10.1146/annurev.nutr.21.1.193ReddyJKHashimotoTPeroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic systemAnnu Rev Nutr20012119323010.1146/annurev.nutr.21.1.19311375435Open DOISearch in Google Scholar
Aoyama T, Peters JM, Iritani N, Nakajima T, Furihata K, Hashimoto T, Gonzalez FJ. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J Biol Chem 1998;273:5678–84. doi: 10.1074/jbc.273.10.5678AoyamaTPetersJMIritaniNNakajimaTFurihataKHashimotoTGonzalezFJAltered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha)J Biol Chem199827356788410.1074/jbc.273.10.5678Open DOISearch in Google Scholar
Vamecq J, Vallee L, Fontaine M, Lambert D, Poupaert J, Nuyts JP. CoA esters of valproic acid and related metabolites are oxidized in peroxisomes through a pathway distinct from peroxisomal fatty and bile acyl-CoA beta-oxidation. FEBS Lett 1993;322:95–100. doi: 10.1016/0014-5793(93)81545-bVamecqJValleeLFontaineMLambertDPoupaertJNuytsJPCoA esters of valproic acid and related metabolites are oxidized in peroxisomes through a pathway distinct from peroxisomal fatty and bile acyl-CoA beta-oxidationFEBS Lett19933229510010.1016/0014-5793(93)81545-bOpen DOISearch in Google Scholar
Ponchaut S, Draye JP, Veitch K, Van Hoof F. Influence of chronic administration of valproate on ultrastructure and enzyme content of peroxisomes in rat liver and kidney. Oxidation of valproate by liver peroxisomes. Biochem Pharmacol 1991;41:1419–28. doi: 10.1016/0006-2952(91)90557-LPonchautSDrayeJPVeitchKVanHoof FInfluence of chronic administration of valproate on ultrastructure and enzyme content of peroxisomes in rat liver and kidneyOxidation of valproate by liver peroxisomes. Biochem Pharmacol19914114192810.1016/0006-2952(91)90557-LOpen DOISearch in Google Scholar
Van den Branden C, Roels F. Peroxisomal beta-oxidation and sodium valproate. Biochem Pharmacol 1985;34:2147–9. doi: 10.1016/00062952(85)90409-5Vanden Branden CRoelsFPeroxisomal beta-oxidation and sodium valproateBiochem Pharmacol1985342147910.1016/00062952(85)90409-5Open DOISearch in Google Scholar
Wang Y, Nakajima T, Gonzalez FJ, Tanaka N. PPARs as metabolic regulators in the liver: lessons from liver-specific PPAR-null mice. Int J Mol Sci 2020;21:2061. doi: 10.3390/ijms21062061WangYNakajimaTGonzalezFJTanakaNPPARs as metabolic regulators in the liver: lessons from liver-specific PPAR-null miceInt J Mol Sci202021206110.3390/ijms21062061Open DOISearch in Google Scholar
McMullen PD, Bhattacharya S, Woods CG, Sun B, Yarborough K, Ross SM, Miller ME, McBride MT, LeCluyse EL, Clewell RA, Andersen ME. A map of the PPARα transcription regulatory network for primary human hepatocytes. Chem Biol Interact 2014;209:14–24. doi: 10.1016/j.cbi.2013.11.006McMullenPDBhattacharyaSWoodsCGSunBYarboroughKRossSMMillerMEMcBrideMTLeCluyseELClewellRAAndersenMEA map of the PPARα transcription regulatory network for primary human hepatocytesChem Biol Interact2014209142410.1016/j.cbi.2013.11.006Open DOISearch in Google Scholar
Varanasi U, Chu R, Huang Q, Castellon R, Yeldandi AV, Reddy JK. Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene. J Biol Chem 1996;271:2147–55. doi: 10.1074/jbc.271.4.2147VaranasiUChuRHuangQCastellonRYeldandiAVReddyJKIdentification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase geneJ Biol Chem199627121475510.1074/jbc.271.4.2147Open DOISearch in Google Scholar
Yaacob NS, Norazmi MN, Gibson GG, Kass GE. The transcription of the peroxisome proliferator-activated receptor alpha gene is regulated by protein kinase C. Toxicol Lett 2001;125:133–41. doi: 10.1016/s0378-4274(01)00433-7YaacobNSNorazmiMNGibsonGGKassGEThe transcription of the peroxisome proliferator-activated receptor alpha gene is regulated by protein kinase CToxicol Lett20011251334110.1016/s0378-4274(01)00433-7Open DOISearch in Google Scholar
Ke JY, Kliewer KL, Hamad EM, Cole RM, Powell KA, Andridge RR, Straka SR, Yee LD, Belury MA. The flavonoid, naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in mice. Nutr Metab (Lond) 2015;12:1. doi: 10.1186/17437075-12-1KeJYKliewerKLHamadEMColeRMPowellKAAndridgeRRStrakaSRYeeLDBeluryMAThe flavonoid, naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in miceNutr Metab (Lond)201512110.1186/17437075-12-1Open DOISearch in Google Scholar
Dayarathne LA, Ranaweera SS, Natraj P, Rajan P, Lee YJ, Han CH. Restoration of the adipogenic gene expression by naringenin and naringin in 3T3-L1 adipocytes. J Vet Sci 2021;22:e55. doi: 10.4142/jvs.2021.22.e55DayarathneLARanaweeraSSNatrajPRajanPLeeYJHanCHRestoration of the adipogenic gene expression by naringenin and naringin in 3T3-L1 adipocytesJ Vet Sci202122e5510.4142/jvs.2021.22.e55831879134313040Open DOISearch in Google Scholar
Zeng J, Deng S, Wang Y, Li P, Tang L, Pang Y. Specific inhibition of acyl-CoA oxidase-1 by an acetylenic acid improves hepatic lipid and reactive oxygen species (ROS) metabolism in rats fed a high fat diet. J Biol Chem 2017;292:3800–9. doi: 10.1074/jbc.M116.763532ZengJDengSWangYLiPTangLPangYSpecific inhibition of acyl-CoA oxidase-1 by an acetylenic acid improves hepatic lipid and reactive oxygen species (ROS) metabolism in rats fed a high fat dietJ Biol Chem20172923800910.1074/jbc.M116.763532Open DOISearch in Google Scholar
Komulainen T, Lodge T, Hinttala R, Bolszak M, Pietilä M, Koivunen P, Hakkola J, Poulton J, Morten KJ, Uusimaa J. Sodium valproate induces mitochondrial respiration dysfunction in HepG2 in vitro cell model. Toxicology 2015;331:47–56. doi: 10.1016/j.tox.2015.03.001KomulainenTLodgeTHinttalaRBolszakMPietiläMKoivunenPHakkolaJPoultonJMortenKJUusimaaJSodium valproate induces mitochondrial respiration dysfunction in HepG2 in vitro cell modelToxicology2015331475610.1016/j.tox.2015.03.001Open DOISearch in Google Scholar
Pourahmad J, Eskandari MR, Kaghazi A, Shaki F, Shahraki J, Fard JK. A new approach on valproic acid induced hepatotoxicity: involvement of lysosomal membrane leakiness and cellular proteolysis. Toxicol In Vitro 2012;26:545–51. doi: 10.1016/j.tiv.2012.01.020PourahmadJEskandariMRKaghaziAShakiFShahrakiJFardJKA new approach on valproic acid induced hepatotoxicity: involvement of lysosomal membrane leakiness and cellular proteolysisToxicol In Vitro2012265455110.1016/j.tiv.2012.01.020Open DOISearch in Google Scholar
Jafarian I, Eskandari MR, Mashayekhi V, Ahadpour M, Hosseini MJ. Toxicity of valproic acid in isolated rat liver mitochondria. Toxicol Mech Methods 2013;23:617–23. doi: 10.3109/15376516.2013.821567JafarianIEskandariMRMashayekhiVAhadpourMHosseiniMJToxicity of valproic acid in isolated rat liver mitochondriaToxicol Mech Methods2013236172310.3109/15376516.2013.821567Open DOISearch in Google Scholar
Jung UJ, Kim HJ, Lee JS, Lee MK, Kim HO, Park EJ, Kim HK, Jeong TS, Choi MS. Naringin supplementation lowers plasma lipids and enhances erythrocyte antioxidant enzyme activities in hypercholesterolemic subjects. Clin Nutr 2003;22:561–8. doi: 10.1016/s0261-5614(03)00059-1JungUJKimHJLeeJSLeeMKKimHOParkEJKimHKJeongTSChoiMSNaringin supplementation lowers plasma lipids and enhances erythrocyte antioxidant enzyme activities in hypercholesterolemic subjectsClin Nutr200322561810.1016/s0261-5614(03)00059-1Open DOISearch in Google Scholar
Demonty I, Lin Y, Zebregs YE, Vermeer MA, van der Knaap HC, Jäkel M, Trautwein EA. The citrus flavonoids hesperidin and naringin do not affect serum cholesterol in moderately hypercholesterolemic men and women. J Nutr 2010;140:1615–20. doi: 10.3945/jn.110.124735DemontyILinYZebregsYEVermeerMAvander Knaap HCJäkelMTrautweinEAThe citrus flavonoids hesperidin and naringin do not affect serum cholesterol in moderately hypercholesterolemic men and womenJ Nutr201014016152010.3945/jn.110.12473520660284Open DOISearch in Google Scholar
Raffoul-Orozco AK, Ávila-González AE, Rodríguez-Razón CM, García-Cobian TA, Pérez-Guerrero EE, García-Iglesias T, Rubio-Arellano ED. Combination effect naringin and pravastatin in lipid profile and glucose in obese rats. Life Sci 2018;193:87–92. doi: 10.1016/j.lfs.2017.11.044Raffoul-OrozcoAKÁvila-GonzálezAERodríguez-RazónCMGarcía-CobianTAPérez-GuerreroEEGarcía-IglesiasTRubio-ArellanoEDCombination effect naringin and pravastatin in lipid profile and glucose in obese ratsLife Sci2018193879210.1016/j.lfs.2017.11.04429197498Open DOISearch in Google Scholar
, , , , , , y | 07 abr 2022